Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

The hidden medication putting Parkinson’s patients at risk

Rebecca Miller, PhD
Meds
October 14, 2024
Share
Tweet
Share

At the doctor’s office, in the ER, in the hospital, how many times are you asked about your drug allergies? A lot! And, as a common practice when in the hospital, you’ll even get a red bracelet or something to indicate such. There are strict rules around allergies; from techs to transport to MDs, hospital staff are well-trained to look for these bracelets and to make sure that you don’t receive anything that you are allergic to. But did you know that, as a person with Parkinson’s disease (PD), you have a drug “allergy”? That medication is haloperidol (commonly known by its trade name, Haldol).

Yes, you may never have heard of this medication, but it is a drug widely used in emergency rooms, on hospital units, and in nursing homes to help calm people down when they are agitated or when they are experiencing delirium. These are not uncommon problems, especially for people who are advanced in age, experiencing certain medical problems like urinary tract infections, or have been in the hospital for multiple days. And those of us with Parkinson’s disease tend to be older, with the average age of onset being age 60. We also tend to be hospitalized fairly often for things unrelated to our PD, and during those hospitalizations, we can experience significant problems like delirium or urinary tract infections. But giving us Haldol can lead to cascading negative consequences, including a higher likelihood of death. What is this drug? Here’s a brief bit about why it is so bad for people with PD.

Haldol and other medications like it are considered major tranquilizers, or first-generation antipsychotics. Haldol is used for psychotic symptoms found in disorders like schizophrenia, as well as for delusions, delirium, or agitation. Other medications in this class include Stelazine, Thorazine, and Prolixin. All of these medications use a similar mechanism of action: they block D2 receptors in the brain. This means, in lay terms, that these drugs all reduce dopamine levels in the brain. Reduce dopamine, you may say. Why, that is the opposite of what a Parkinson’s person needs! All the other medications for Parkinson’s are trying to increase dopamine. Yes. So this medication, if given to a person with Parkinson’s, can lead to a severe increase in symptoms that can mean losing the ability to walk and talk. And that is why I, as a person with Parkinson’s, decided to list Haldol as a medication on my allergy list.

I am not actually “allergic” in the traditional sense to this medication. It doesn’t give me a rash or make my throat close; I don’t experience anything like anaphylaxis. But it is listed as a contraindicated medication for people with Parkinson’s disease. What does “contraindicated” mean? More specifically, it indicates that the particular treatment or drug is potentially harmful to that particular person, either because of other medications they are taking or because of the disease they have. Sort of like giving a giant chocolate bar to someone with diabetes. Unfortunately, in the current medical system in the United States, there is no systematic way or specific place to list contraindicated drugs (of which there are others for Parkinson’s) that is similar to the “allergy” alert. So, I have been testing out having Haldol listed as an allergy for me in my medical record to see if it is helpful.

So far, this has sparked several conversations with medical staff when I am asked what my reaction to the medication is, like any allergy, as the question comes up whenever my allergy list is reviewed. I answer that I have Parkinson’s and that Haldol reduces dopamine. It is a chance to also educate nurses and other medical staff about this contraindication for people with Parkinson’s. So, next time you or your loved one with Parkinson’s visits their primary care provider or neurologist, ask about having Haldol listed as a medication to which you are allergic. Or, even better, add it to your own electronic medical record, if that is doable for you. Don’t let your disease take charge of you, take charge of your disease! These were words spoken to me upon my diagnosis, and I pass them along to you. Until the medical system catches up with safety measures to protect us as people with PD, we need to “hack” the system in positive ways that keep us safe.

Rebecca Miller is a clinical psychologist.

Prev

How food marketing to kids is harming their health and what we can do [PODCAST]

October 13, 2024 Kevin 0
…
Next

The dangerous shift in mental health: Are we clients or patients?

October 14, 2024 Kevin 0
…

Tagged as: Neurology

Post navigation

< Previous Post
How food marketing to kids is harming their health and what we can do [PODCAST]
Next Post >
The dangerous shift in mental health: Are we clients or patients?

ADVERTISEMENT

More by Rebecca Miller, PhD

  • It’s not brain surgery: People with Parkinson’s need better care in the hospital

    Rebecca Miller, PhD

Related Posts

  • When records are wrong, patients are at risk

    Denise Reich
  • You are abandoning your patients if you are not active on social media

    Pat Rich
  • The life cycle of medication consumption

    Fery Pashang, PharmD
  • Practicing patience with patients

    Natalie Enyedi
  • Expensive Medicare patients aren’t who you think

    Peter Ubel, MD
  • Under-addressed mediators of adherence: personality in patients

    Trisha Kaundinya

More in Meds

  • Why kratom addiction is the next public health crisis

    Muhamad Aly Rifai, MD
  • FDA delays could end vital treatment for rare disease patients

    GJ van Londen, MD
  • Pharmacists are key to expanding Medicaid access to digital therapeutics

    Amanda Matter
  • How medicine repurposing enables value-based pain management and insomnia therapy

    Olumuyiwa Bamgbade, MD
  • Forced voicemail and diagnosis codes are endangering patient access to medications

    Arthur Lazarus, MD, MBA
  • From stigma to science: Rethinking the U.S. drug scheduling system

    Artin Asadipooya
  • Most Popular

  • Past Week

    • New student loan caps could shut low-income students out of medicine

      Tom Phan, MD | Physician
    • What street medicine taught me about healing

      Alina Kang | Education
    • Are we repeating the statin playbook with lipoprotein(a)?

      Larry Kaskel, MD | Conditions
    • The silent cost of choosing personalization over privacy in health care

      Dr. Giriraj Tosh Purohit | Tech
    • Why transgender health care needs urgent reform and inclusive practices

      Angela Rodriguez, MD | Conditions
    • mRNA post vaccination syndrome: Is it real?

      Harry Oken, MD | Conditions
  • Past 6 Months

    • COVID-19 was real: a doctor’s frontline account

      Randall S. Fong, MD | Conditions
    • Why primary care doctors are drowning in debt despite saving lives

      John Wei, MD | Physician
    • New student loan caps could shut low-income students out of medicine

      Tom Phan, MD | Physician
    • Confessions of a lipidologist in recovery: the infection we’ve ignored for 40 years

      Larry Kaskel, MD | Conditions
    • A physician employment agreement term that often tricks physicians

      Dennis Hursh, Esq | Finance
    • Why taxing remittances harms families and global health care

      Dalia Saha, MD | Finance
  • Recent Posts

    • A systemic plan for health worker well-being [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why pain doctors face unfair scrutiny and harsh penalties in California

      Kayvan Haddadan, MD | Physician
    • Why physicians need a place to fall apart

      Annia Raja, PhD | Physician
    • The joy of teaching medicine through life’s toughest challenges

      John F. McGeehan, MD | Physician
    • Why health care can’t survive on no-fail missions alone

      Wendy Schofer, MD | Physician
    • An addiction physician’s warning about America’s next public health crisis [PODCAST]

      The Podcast by KevinMD | Podcast

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 1 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • New student loan caps could shut low-income students out of medicine

      Tom Phan, MD | Physician
    • What street medicine taught me about healing

      Alina Kang | Education
    • Are we repeating the statin playbook with lipoprotein(a)?

      Larry Kaskel, MD | Conditions
    • The silent cost of choosing personalization over privacy in health care

      Dr. Giriraj Tosh Purohit | Tech
    • Why transgender health care needs urgent reform and inclusive practices

      Angela Rodriguez, MD | Conditions
    • mRNA post vaccination syndrome: Is it real?

      Harry Oken, MD | Conditions
  • Past 6 Months

    • COVID-19 was real: a doctor’s frontline account

      Randall S. Fong, MD | Conditions
    • Why primary care doctors are drowning in debt despite saving lives

      John Wei, MD | Physician
    • New student loan caps could shut low-income students out of medicine

      Tom Phan, MD | Physician
    • Confessions of a lipidologist in recovery: the infection we’ve ignored for 40 years

      Larry Kaskel, MD | Conditions
    • A physician employment agreement term that often tricks physicians

      Dennis Hursh, Esq | Finance
    • Why taxing remittances harms families and global health care

      Dalia Saha, MD | Finance
  • Recent Posts

    • A systemic plan for health worker well-being [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why pain doctors face unfair scrutiny and harsh penalties in California

      Kayvan Haddadan, MD | Physician
    • Why physicians need a place to fall apart

      Annia Raja, PhD | Physician
    • The joy of teaching medicine through life’s toughest challenges

      John F. McGeehan, MD | Physician
    • Why health care can’t survive on no-fail missions alone

      Wendy Schofer, MD | Physician
    • An addiction physician’s warning about America’s next public health crisis [PODCAST]

      The Podcast by KevinMD | Podcast

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

The hidden medication putting Parkinson’s patients at risk
1 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...